A Case Series of 13 Patients with COVID-19 Associated Respiratory Symptoms Treated with Nebulized OTR4120 (Cacipliq20®). Archives of Clinical and Medical Case Reports, v. 6, n. 4, p. 604–610, 26 Aug.2022.